Roubaix Capital’s Apyx Medical APYX Stock Holding History

Roubaix Capital’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-180,874	Closed	-$1.75M	–	43
2021 Q1	$1.75M	Buy	+180,874	New	+$1.81M	1.18%	44

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Roubaix Capital's APYX Position: Q2 2021 in Review

Roubaix Capital sold out of Apyx Medical (APYX) in Q2 2021, closing a stake of 180,874 shares — an estimated $1.75M sold.

Roubaix Capital first reported a position in APYX in Q1 2021 and held it in 1 quarter. The position peaked at $1.75M in Q1 2021. 72 funds tracked by Wall St. Rank hold APYX as of Q2 2021.

Roubaix Capital reported no remaining Apyx Medical position as of Q2 2021 after selling out during the quarter.
Roubaix Capital sold 180,874 Apyx Medical shares in Q2 2021, an estimated $1.75M.
Roubaix Capital first reported a position in Apyx Medical in Q1 2021 and held it in 1 quarter.
Roubaix Capital's Apyx Medical position peaked at $1.75M in Q1 2021.
72 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2021.

Based on Roubaix Capital's 13F filing for Q2 2021, filed 22 Jul 2021.